Long-term Outcomes of Patients With Primary Biliary Cirrhosis and Hepatocellular Carcinoma  Mohamad H. Imam, Marina G. Silveira, Emmanouil Sinakos, Andrea A. Gossard, Roberta Jorgensen, Jill Keach, Alisha C. DeCook, Keith D. Lindor  Clinical Gastroenterology and Hepatology  Volume 10, Issue 2, Pages 182-185 (February 2012) DOI: 10.1016/j.cgh.2011.09.013 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Kaplan–Meier curve showing survival in PBC patients after diagnosis of HCC. Data were censored for patients who were alive at the end of the follow-up evaluation. Clinical Gastroenterology and Hepatology 2012 10, 182-185DOI: (10.1016/j.cgh.2011.09.013) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Survival as a function of tumor size in PBC patients developing HCC. Clinical Gastroenterology and Hepatology 2012 10, 182-185DOI: (10.1016/j.cgh.2011.09.013) Copyright © 2012 AGA Institute Terms and Conditions

Figure 3 Kaplan–Meier curve contrasting survival between groups meeting and not meeting Milan criteria. Data were censored for patients who were alive at the end of the follow-up period. P value was determined by using log-rank. Clinical Gastroenterology and Hepatology 2012 10, 182-185DOI: (10.1016/j.cgh.2011.09.013) Copyright © 2012 AGA Institute Terms and Conditions

Figure 4 Transplant survival Kaplan–Meier curves contrasting survival between patients undergoing transplantation or not. Data were censored for patients who were alive at the end of the follow-up period. P value was determined by using log-rank. Clinical Gastroenterology and Hepatology 2012 10, 182-185DOI: (10.1016/j.cgh.2011.09.013) Copyright © 2012 AGA Institute Terms and Conditions